Pharmaceuticals in Brazil

Date: September 26, 2016
Pages: 31
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P1EAEB78A4AEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Brazil
SUMMARY

Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Brazil
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Brazil pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Brazil pharmaceuticals market by value in 2015?
  • What will be the size of the Brazil pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Brazil pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Brazil's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Brazilian pharmaceuticals market had total revenues of $13.9bn in 2015, representing a compound annual growth rate (CAGR) of 9.5% between 2011 and 2015.

A large generic shift is expected in the next few years as significant increases in government spending on free and heavily-subsidized drugs will decelerate as the government shifts its focus to cost-containment, coupled with many big patents expiring.

The performance of the market is forecast to decelerate, with an anticipated CAGR of 6.7% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $19.2bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Aché Laboratories Farmacêuticos S.A.
EMS Sigma Pharma
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Brazil pharmaceuticals market value: $ billion, 2011-15
Table 2: Brazil pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Brazil pharmaceuticals market share: % share, by value, 2015
Table 4: Brazil pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Aché Laboratories Farmacêuticos S.A.: key facts
Table 6: EMS Sigma Pharma: key facts
Table 7: Sanofi SA: key facts
Table 8: Sanofi SA: key financials ($)
Table 9: Sanofi SA: key financials (€)
Table 10: Sanofi SA: key financial ratios
Table 11: Brazil size of population (million), 2011-15
Table 12: Brazil gdp (constant 2005 prices, $ billion), 2011-15
Table 13: Brazil gdp (current prices, $ billion), 2011-15
Table 14: Brazil inflation, 2011-15
Table 15: Brazil consumer price index (absolute), 2011-15
Table 16: Brazil exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Brazil pharmaceuticals market value: $ billion, 2011-15
Figure 2: Brazil pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Brazil pharmaceuticals market share: % share, by value, 2015
Figure 4: Brazil pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Brazil, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Brazil, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Brazil, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2015
Figure 11: Sanofi SA: revenues and profitability
Figure 12: Sanofi SA: assets and liabilities

COMPANIES MENTIONED

Aché Laboratories Farmacêuticos S.A.
EMS Sigma Pharma
Sanofi SA
Skip to top


Ask Your Question

Pharmaceuticals in Brazil
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: